治疗软组织肉瘤的50名患者用埃里布林治疗的临床结局:单一机构的回顾性研究
Yudai Murayama1,2, Rumi Nakagawa1, Yasutaka Sukawa3
1Division of Musculoskeletal Oncology and Orthopedic Surgery, Tochigi Cancer Center, 4-9-13 Yonan, Utsunomiya, Tochigi 320-0834, Japan.
Japanese journal of clinical oncology
|January 25, 2026
概括
埃里布林在软组织肉瘤 (STS) 患者中显示出良好的耐受性和疾病控制. 修改剂量计划是可行的,支持其在个性化治疗策略中的使用.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 埃里布林在日本已被批准用于软组织肉瘤 (STS).
- 有限的现实世界数据存在于不同STS患者群体中的埃里布林的安全性,疗效和剂量.
- 本研究评估了STS中埃里布林的临床结果,耐受性和预后因素.
研究的目的:
- 评估埃里布林在软组织肉瘤 (STS) 患者的实际安全性和有效性.
- 探索最佳的剂量策略,并确定在STS中治疗埃里布林的预后因素.
- 评估临床结果,包括疾病控制,无进展生存 (PFS) 和整体生存 (OS).
主要方法:
- 对50名接受埃里布林治疗的STS患者 (2018-2024) 的回顾性审查.
- 对临床变量,剂量表,瘤反应,不良事件 (AE),PFS和OS的分析.
- 卡普兰-梅尔生存率估计方法; 群组比较的日志等级测试.
主要成果:
- 平均年龄为66岁;疾病控制率为62% (1个完整,1个部分响应).
- 中位数PFS为4个月,中位数OS为19个月.
- 血液毒性最常见的是3级以上的有害事件;没有心脏事件. 可行的修改剂量 (每周两次,两次给药/两周休息时间使用佩格菲尔格拉斯蒂姆) 显示了持久的治疗.
结论:
- 埃里布林在各种STS亚组中表现出良好的耐受性和持久的疾病控制能力,包括老年人/并发症患者.
- 修改剂量计划 (每周两次,每周两次/每周两周休息) 是可行的,并且耐受良好.
- 这些发现支持将埃里布林纳入个性化STS治疗中,为优化剂量和患者选择提供前性研究.
相关概念视频
Predicting Reaction Outcomes
10.4K
Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
10.4K
Aneurysm II: Clinical Manifestations and Diagnostic Studies
334
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
334
Outcomes of Glycolysis
106.8K
Nearly all the energy used by cells comes from the bonds that make up complex organic compounds. These organic compounds are broken down into simpler molecules, such as glucose. As a result, cells extract energy from glucose over many chemical reactions—a process called cellular respiration.
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
106.8K
Hypertension III: Clinical Manifestations and Diagnostic Studies
491
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
491
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
332
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
332
Rous Sarcoma Virus (RSV) and Cancer
6.3K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.3K


